SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses potential partnerships and adoption by major players. Chatter revolves around Pyth's role in the Real World Asset (RWA) space, with some speculating on future price targets. Discussions also highlight the potential impact of institutional adoption and expansion into new markets.

Ainalyzr is a versatile and engaging platform designed to provide crypto traders with advanced tools and a fun, interactive environment. Powered by the Ainalyzr token, it offers real-time analysis of Solana-based tokens, gamified trading tools, and a space for users to explore market trends and make data-driven decisions. Ainalyzr merges functionality and entertainment, appealing to both seasoned and novice traders.

AInalyzr

AInalyzr ($AINAL.X) is gaining traction as the community highlights its potential for significant growth. Investors are discussing its "sleeper gem" qualities and anticipating a potential "lift off". The project's mint and association with other cryptocurrencies like Bitcoin and Solana are central to the conversation.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community anticipates a potential ETF, with many discussing key price levels and expressing bullish sentiment. Some are pointing to technical indicators suggesting a possible breakout and expressing excitement about potential gains. The broader crypto market trends and potential rate cuts are also fueling optimism.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight its strong chart setup, coiling pattern, and potential for a breakout. Discussions revolve around accumulation phases, steady bullish momentum, and the anticipation of a significant upward move. The community also notes growing awareness and potential partnerships, contributing to the bullish sentiment.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock price rallies, fueled by momentum in its energy business and speculation around future AI and robotics initiatives. The community is actively debating whether this surge is justified by fundamentals or driven by market manipulation, with some pointing to a potential short squeeze while others highlight concerns about insider selling and product safety. Discussions also include broader market conditions and potential impacts on the EV sector.

Trump For President

The TRUMP.X crypto is trending amid discussions about a potential ETF and its correlation with other cryptos like BTC and ETH. Community members are debating its future value, especially if Trump actively supports or acknowledges the coin, while also commenting on his recent summit with Putin. Political opinions and sentiments toward Trump are heavily influencing the conversation around this speculative asset.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is trending as the community discusses potential breakouts and compares it to other meme coins like Doge and Shib. Some users are expressing frustration with price fluctuations, while others remain optimistic about long-term gains and potential rallies. The conversation also includes mentions of potential market manipulation and the broader meme coin sector.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

ATYR is trending as traders anticipate Phase 3 EFZO-FIT data, expected mid-September, focusing on pulmonary sarcoidosis treatment. The community is actively discussing aggressive ask-side put sweeps, high implied volatility, and potential binary gap risk, while also debating the significance of recent analyst ratings and commercial hires. Some traders are weighing defined-risk setups and hedging strategies amid the uncertainty.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amidst heated discussions surrounding a recent tragedy, with community members expressing strong opinions and political divides seemingly amplified.  Conversations are centered on the motivations and affiliations of individuals involved, sparking debates about extremist ideologies and the impact of political rhetoric.  The stock's movement is secondary to the intense social and political commentary.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as community members discuss the potential impact of treasury companies and a large purchase from Galaxy Digital, speculating on a possible surge toward new price levels. The conversation includes discussion around meme coins on the Solana network. Some users are suggesting that Solana could overtake other cryptocurrencies in market capitalization.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Global Equity ETFs Draw Rising Investor Interest

Global equity funds saw $10.65B inflows as Fed rate cut bets, a weak dollar and diversification needs drive investors abroad.

Is Schwab Fundamental International Equity ETF (FNDF) a Strong ETF Right Now?

Is JPMorgan Diversified Return International Equity ETF (JPIN) a Strong ETF Right Now?

Is Vident International Equity Strategy ETF (VIDI) a Strong ETF Right Now?

Is ALPS International Sector Dividend Dogs ETF (IDOG) a Strong ETF Right Now?

U.S.-listed shares of BioNTech SE ended Monday nearly 3.2% lower, weighed down by a weak full-year revenue projection even as the German drugmaker posted a quarterly earnings beat. Retail traders, however, did not appear too shaken.Fourth-quarter revenue fell to 1.19 billion euros ($1.29 billion) from 1.48 billion euros a year earlier — as demand for COVID-19 vaccines shrank — but was better than Wall Street's estimate of 1.09 billion euros.&nbsp;Likewise, Q4 earnings per share (EPS) fell to 1.08 euros from 1.88 euros a year earlier but easily topped a consensus estimate of 0.41 euros.&nbsp;The company said clinical studies for late-stage oncology candidates raised research and development (R&amp;D) expenses by nearly 6%.For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros. The bulk of the sales are expected to come in the final quarter of 2025.The outlook factors in stable vaccination trends, Pfizer-related inventory write-downs, revenue from Germany's pandemic preparedness deal, and BioNTech's service businesses.The company anticipates full-year R&amp;D costs rising to 2.6 billion euros to 2.8 billion euros from 2.25 billion euros in 2024, primarily due to late-stage development and commercial readiness in oncology.Following the results, BofA Securities lowered its price target on BioNTech to $143 from $147 but kept a 'Buy' rating on the shares, noting that 2024 COVID-19 revenue was higher than consensus estimates.However, the research firm flagged potential vaccination policy risks in the U.S. and other regions, saying it would monitor trends in 2025 while remaining optimistic about BioNTech's oncology pipeline, which includes over 20 late-stage trials. Multiple data readouts are expected this year and next.On Stocktwits, sentiment for BioNTech ended on a 'bullish' note on Monday amid a 600% spike in message volume, with shares climbing after the closing bell.<figure class="image"><img style="aspect-ratio:1316/302;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/BNTX_sentiment_and_message_volume_as_of_March_10_2c73debe23.png" alt="BNTX sentiment and message volume as of March 10.png" width="1316" height="302"><figcaption>BNTX sentiment and message volume as of March 10 | source: Stocktwits</figcaption></figure>Amid some cautiousness over BioNTech's cash burn, optimistic watchers pinned hopes on the company's oncology pipeline and relatively cheap valuation.&nbsp;<stembedurl>https://stocktwits.com/Robert321/message/607415401</stembedurl><stembedurl>https://stocktwits.com/taxplanr/message/607554091</stembedurl>BioNTech trades at a forward enterprise value-to-sales ratio multiple of 2.5, compared to Pfizer's 3.1 and Eli Lilly &amp; Co's 13.1.Shares are down over 8% this year but have gained 15.6% in the past 12 months.BioNTech stock trades 38% below the average price target of $145.54 set by 21 Wall Street analysts. Of these, 12 rate it a 'Buy,' five a 'Strong Buy,' and four a 'Hold,' according to Koyfin data.(1 euro=$1.08)For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the BioNTech logo is displayed on a smartphone screen. (Photo illustration by Cheng Xin/Getty Images)

BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic

For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros.

Equity

Schwab Strategic Trust - CSIM Schwab Fundamental International Large Company Index ETF

Fed policy & rates

Earnings reports

Economic data

Geopolitics & news

What will be the primary driver of the market next week?

Current Price	$27.89
Prev Close	$27.73
Open	$27.90
Dividend Yield	N/A
50-Day Moving Average	$27.54
Beta	N/A
Avg. Volume	410,523.86
PE Ratio	N/A

52-Week High	$30.49
52-Week Low	$24.35
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

FNDF
Schwab Strategic Trust - Schwab Fundamental International Large Company Index ETF

Feed

News

Sentiment

Fundamentals

Info

Latest FNDF News

FNDF Schwab Strategic Trust - Schwab Fundamental International Large Company Index ETF